Wanbury Limited (BOM:524212)
India · Delayed Price · Currency is INR 287.25
+4.10 (1.45%)
At close: May 26, 2026
Wanbury Market Cap
Wanbury has a market cap or net worth of 10.02 billion as of May 27, 2026. Its market cap has increased by 27.18% in one year.
Market Cap
10.02B
Enterprise Value
11.88B
Revenue
6.58B
Ranking
n/a
PE Ratio
14.94
Stock Price
287.25
Market Cap Chart
Since February 7, 2005, Wanbury's market cap has increased from 1.77B to 10.02B, an increase of 466.97%. That is a compound annual growth rate of 8.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 10.02B | 26.46% |
| Dec 31, 2025 | 7.93B | -17.28% |
| Dec 31, 2024 | 9.58B | 121.65% |
| Dec 29, 2023 | 4.32B | 169.44% |
| Dec 30, 2022 | 1.60B | -40.72% |
| Dec 31, 2021 | 2.71B | 135.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syncom Formulations (India) | 14.89B |
| Lincoln Pharmaceuticals | 14.37B |
| Fredun Pharmaceuticals | 13.14B |
| TTK Healthcare | 12.57B |
| Shukra Pharmaceuticals | 12.32B |
| Bharat Parenterals | 9.20B |
| Kopran | 9.11B |
| Fermenta Biotech | 8.89B |